Long Position on CDXS @ $21.80 on 2/21/2019 (Momentum)

Codexis, Inc. (CDXS) discovers, develops, and sells protein catalysts.

It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening.

The company also provides protein catalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering protein catalysts that perform chemical transformations.

The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes.

Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients.

The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company is scheduled to report its results on March 10th. Ahead of that, shares have formed a bullish "flag" and higher share prices are expected for this stock.

Entry Point: $21.80

Stop Loss: $20.70

Trading Range: $8.85 to $23.05

Target Price: $24.00

Updates

3/5/2019 12:11:07 PM

CDXS closed at $19.55

Position closed on 3/5/2019 at price of $19.55 with a -10.32% loss in 12 days.

Back to Portfolio